News Search Results
Apr 21, 2025, 08:24 ET BIO Asia-Taiwan Kicks Off on an Expanded Scale July 23
Zone, participating companies include PharmaEssentia, MycoMagic Biotechnology, Golden Biotechnology, Foresee Pharmaceuticals, Wendy International, Formosa Pharmaceuticals, AP Biosciences, TAHO Pharmaceuticals, Charsire Biotechnology, Elixiron Immunotherapeutics, BoYen Therapeutics, WCC Biomedical, Transin
More news about: Taiwan Bio Industry Organization
Apr 21, 2025, 08:00 ET Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals
approximately 60.6 million shares on a fully-diluted basis. About Aerovate Therapeutics, Inc. Aerovate Therapeutics is a biotechnology company that was focused on improving the lives of patients with rare cardiopulmonary disease. For more information, please visit
More news about: Aerovate Therapeutics
Apr 21, 2025, 07:00 ET SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. (NASDAQ: SANA) between March 17, 2023 and November 4, 2024, both dates inclusive
More news about: THE ROSEN LAW FIRM, P. A.
Apr 21, 2025, 07:00 ET Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
SHANGHAI, April 21, 2025 /PRNewswire/ -- Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering
More news about: Rona Therapeutics
Apr 21, 2025, 07:00 ET Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
SHANGHAI, April 21, 2025 /PRNewswire/ -- Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering
More news about: Rona Therapeutics
Apr 21, 2025, 07:00 ET Acepodia Presents Preclinical Data on Antibody-Dual-Drugs Conjugation (AD2C) technology at AACR Annual Meeting 2025
therapeutic payloads using bioorthogonal click chemistry. About AcepodiaAcepodia (6976.TT) is a clinical-stage biotechnology company headquartered in Taipei and Alameda, California, advancing innovative
More news about: Acepodia Inc.
Apr 21, 2025, 07:00 ET CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program
New Jersey Technology Business Tax Certificate Transfer Program enables approved Technology and Biotechnology Businesses with Net Operating Losses to sell their Unused Net Operating Loss (NOL) and Unused Research and Development Tax Credits (R&D Tax
More news about: CytoSorbents Corporation
Apr 21, 2025, 06:07 ET NASA Science, Cargo Launch on 32nd SpaceX Resupply Station Mission
investigations conducted aboard the orbiting laboratory each year in the areas of biology and biotechnology, physical sciences, and Earth and space science. Such research benefits humanity and helps lay the groundwork for future human exploration through
More news about: NASA
Apr 21, 2025, 05:45 ET The Gross Law Firm Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
More news about: The Gross Law Firm
Apr 18, 2025, 05:45 ET Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline
April 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ("Sana Biotechnology, Inc." or the "Company") (NASDAQ: SANA) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Apr 17, 2025, 20:00 ET 鈦隼生技が第一金証券と提携し、上場支援計画を開始
竹北市、2025年4月18日/PRNewswire/ -- 鈦隼生物科技股份有限公司（Brain Navi Biotechnology Co., Ltd.、以下「ブレインナビ」と略称）は、第一金証券（本社 高雄市）とIPO支援契約を締結し、正式に上場支援計画を開始しました。これにより、資本市場への進出を目指します。
More news about: Brain Navi
Apr 17, 2025, 11:03 ET James Gromann Joins Rubin and Rudman's Real Estate Practice Group
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Apr 17, 2025, 11:00 ET Scion Life Sciences Expands Team with Appointment of Three Venture Partners
April 17, 2025 /PRNewswire/ -- Scion Life Sciences ("Scion"), a venture capital firm dedicated to founding and building exceptional biotechnology companies, today announced the appointment of Lalo Flores, Ph.D., Huw Nash, Ph.D.
More news about: Scion Life Sciences
Apr 17, 2025, 10:00 ET Monument Therapeutics Announces Appointment of Robert Radie as Chair and Heather Preston to Advisory Board
pharmaceutical company acquired by Sanofi Pasteur, and Transmolecular, Inc., a biotechnology company developing cancer diagnostics and treatments. He has also held senior positions in a number of pharmaceutical and biotechnology companies, including Morphotek and Vicuron Pharmaceuticals, and currently serves
More news about: Monument Therapeutics
Apr 17, 2025, 10:00 ET Lilly confirms date and conference call for first-quarter 2025 financial results announcement
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Apr 17, 2025, 09:00 ET BioMarin to Host First Quarter 2025 Financial Results Conference Call and Webcast on Thursday, May 1, 2025, at 4:30pm ET
https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call. About BioMarinBioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The
More news about: BioMarin Pharmaceutical Inc.
Apr 17, 2025, 07:30 ET Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
Apr 17, 2025, 07:15 ET Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
thriving in one of the most challenging biotechnology environments in a generation: Delivered total stockholder returns of 267% over the past five years, far exceeding the performance of the NASDAQ Biotechnology Index and the S&P Biotechnology Select Industry Index3.Achieved
More news about: Dynavax Technologies
Apr 17, 2025, 07:00 ET Eugène Riconneaus introduces ER Ocean Recherche - Redesigning fashion materials in a laboratory
ER Ocean Recherche, a pioneering project at the intersection of material design, biotechnology, and environmental responsibility. Inspired by biomimicry, this initiative transforms one of the ocean's most overlooked resources—marine biomass—into
More news about: ER Ocean Recherche
Apr 17, 2025, 06:45 ET Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Apr 17, 2025, 05:45 ET The Gross Law Firm Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA
April 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. (NASDAQ: SANA).
More news about: The Gross Law Firm
Apr 16, 2025, 11:03 ET NEUVOGEN Appoints James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D to its Scientific Advisory Board
April 16, 2025 /PRNewswire/ -- NEUVOGEN, Inc., a San Diego based biotechnology company with a next-generation cancer vaccine platform, announced today the appointments of James P. Allison, Ph.D.,
More news about: NEUVOGEN, Inc.
Apr 16, 2025, 09:00 ET Petauri Unites Mtech Access and Delta Hat Under One Team--Petauri Evidence
Petauri Evidence is dedicated to helping pharmaceutical, biotechnology, and medical device companies generate and apply real-world evidence to inform healthcare decision-making. By integrating Mtech Access's established
More news about: Petauri
Apr 16, 2025, 08:00 ET Nanostics Receives CPSA Accreditation for its Newly Relocated Clinical Laboratory at the Biotechnology Business Development Centre in Edmonton
Nanostics clinical lab relocates to Applied Pharmaceutical Innovation's newly upgraded Biotechnology Business Development Centre in the Edmonton Research Park.Nanostics clinical lab has been granted provisional accreditation from the College of Physicians
More news about: Nanostics
Apr 16, 2025, 07:36 ET Global Health Innovators recognised with Abu Dhabi Global Health Week Innovation Awards for transformative impact
contributions are advancing the future of health. Winners of the ADGHW Innovation Awards 2025 were recognised for pioneering solutions in digital health, biotechnology, and diagnostics, receiving global recognition and a share of the $200,000 prize fund.
More news about: Abu Dhabi Global Health Week (ADGHW)